Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis

@article{Heby2007TargetingTP,
  title={Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas’ disease, and leishmaniasis},
  author={O. Heby and L. Persson and M. Rentala},
  journal={Amino Acids},
  year={2007},
  volume={33},
  pages={359-366}
}
  • O. Heby, L. Persson, M. Rentala
  • Published 2007
  • Biology, Medicine
  • Amino Acids
  • Summary.Trypanosomatids depend on spermidine for growth and survival. Consequently, enzymes involved in spermidine synthesis and utilization, i.e. arginase, ornithine decarboxylase (ODC), S-adenosylmethionine decarboxylase (AdoMetDC), spermidine synthase, trypanothione synthetase (TryS), and trypanothione reductase (TryR), are promising targets for drug development. The ODC inhibitor α-difluoromethylornithine (DFMO) is about to become a first-line drug against human late-stage gambiense… CONTINUE READING
    Trypanosoma cruzi targets for new chemotherapeutic approaches
    56

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 58 REFERENCES
    Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor.
    62
    Polyamine metabolism: a potential therapeutic target in trypanosomes.
    216
    Sensitivity of trypanosomatid protozoa to DFMO and metabolic turnover of ornithine decarboxylase.
    24
    Antileishmanial Effect of 3-Aminooxy-1-Aminopropane Is Due to Polyamine Depletion
    35
    In vivo trypanocidal activities of new S-adenosylmethionine decarboxylase inhibitors.
    66